Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Torre

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|May 2, 2002
Amantadine: a different approachFrancesco Torre, Antonino Picciotto
Cancer|May 11, 2005
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapyMonica Basso, Francesco Torre, Antonino Picciotto
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 21, 2006
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis CNicoletta Pelli, Francesco Torre, Andrea Delfino, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|April 1, 2011
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patientsFrancesco Torre, Edoardo G Giannini, Monica Basso, et al.
The Journal of Physical Chemistry. A|July 8, 2024
Water Dimer under Electric Fields: An <i>Ab Initio</i> Investigation up to Quantum AccuracyMarco Francesco Torre, Alessandro Amadeo, Giuseppe Cassone, et al.
Hepatology (Baltimore, Md.)|April 8, 2009
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapseMonica Basso, Edoardo G Giannini, Francesco Torre, et al.
Frontiers in Medicine|December 28, 2020
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary GlomerulonephritisRossella Siligato, Guido Gembillo, Valeria Cernaro, et al.
International Journal of Molecular Sciences|April 26, 2020
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis DSandro La Vignera, Rossella Cannarella, Rosita A Condorelli, et al.
Journal of Clinical and Experimental Hepatology|September 14, 2019
Regression of Fibrosis After Direct-acting Antivirals Treatment of Patients with Hepatitis C Virus Cirrhosis: Transposability to Nondecompensated PatientsEdoardo G Giannini, Mattia Crespi, Mariagiulia Demarzo, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 24, 2020
SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancerSandro La Vignera, Rossella Cannarella, Rosita A Condorelli, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|May 2, 2002
Amantadine: a different approachFrancesco Torre, Antonino Picciotto
Cancer|May 11, 2005
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapyMonica Basso, Francesco Torre, Antonino Picciotto
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 21, 2006
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis CNicoletta Pelli, Francesco Torre, Andrea Delfino, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|April 1, 2011
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patientsFrancesco Torre, Edoardo G Giannini, Monica Basso, et al.
The Journal of Physical Chemistry. A|July 8, 2024
Water Dimer under Electric Fields: An <i>Ab Initio</i> Investigation up to Quantum AccuracyMarco Francesco Torre, Alessandro Amadeo, Giuseppe Cassone, et al.
Hepatology (Baltimore, Md.)|April 8, 2009
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapseMonica Basso, Edoardo G Giannini, Francesco Torre, et al.
Frontiers in Medicine|December 28, 2020
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary GlomerulonephritisRossella Siligato, Guido Gembillo, Valeria Cernaro, et al.
International Journal of Molecular Sciences|April 26, 2020
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis DSandro La Vignera, Rossella Cannarella, Rosita A Condorelli, et al.
Journal of Clinical and Experimental Hepatology|September 14, 2019
Regression of Fibrosis After Direct-acting Antivirals Treatment of Patients with Hepatitis C Virus Cirrhosis: Transposability to Nondecompensated PatientsEdoardo G Giannini, Mattia Crespi, Mariagiulia Demarzo, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 24, 2020
SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancerSandro La Vignera, Rossella Cannarella, Rosita A Condorelli, et al.
Pageof 3